Prostate cancer risk: The significance of age-related differences in PSA velocity between men with and without biopsy-proven prostate cancers

被引：0
|
作者：
Bektic, Jasmin
Pelzer, Alexandre E.
Schaefer, Georg
Bartsch, Georg
Horninger, Wolfgang
机构：
来源：
JOURNAL OF UROLOGY | 2007年 / 177卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：580 / 580
页数：1
相关论文
共 50 条
  • [41] Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: Age-specific reference ranges for total PSA, free PSA, and percent free PSA
    Kalish, LA
    McKinlay, JB
    UROLOGY, 1999, 54 (06) : 1022 - 1027
  • [42] MIDLIFE BASELINE PSA AS A PREDICTOR OF LETHAL PROSTATE CANCER: RACIAL DIFFERENCES BETWEEN BLACK AND WHITE MEN
    Chiarelli, Giuseppe
    Matthew, Davis
    Stephens, Alex
    Finati, Marco
    Cirulli, Giuseppe O.
    Morrison, Chase
    Tinsley, Shane
    Sood, Akshay
    Carrieri, Giuseppe
    Briganti, Alberto
    Montorsi, Francesco
    Lughezzani, Giovanni
    Buffi, Nicolo
    Rogers, Craig
    Abdollah, Firas
    JOURNAL OF UROLOGY, 2024, 211 (05): : E310 - E310
  • [43] Association between age-related parameters and acute toxicity in prostate cancer radiotherapy
    Paal, K.
    Stranz, B.
    Thurner, E.
    Langsenlehner, T.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1242 - S1242
  • [44] Age-specific serum levels of PSA, complexed PSA (cPSA) and percent cPSA in men without clinical evidence of prostate cancer, men with benign prostatic hypertrophy (BPH) and those with prostate cancer (CaP).
    Cheli, CD
    Cook, GB
    Neaman, I
    Goldblatt, JL
    Hussain, M
    Loughlin, K
    Schwartz, MK
    Yeung, KK
    Allard, WJ
    CLINICAL CHEMISTRY, 2000, 46 (06) : A157 - A157
  • [45] Use and Misuse of Nomograms for Prostate Cancer Detection Without Consideration of Analytical Differences Between PSA Assays
    Siemssen, K.
    Stephan, Carsten
    Cammann, Henning
    Jung, Klaus
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2009, 14 : 116 - 116
  • [46] Dynamic 18F-DCFPyL PET/CT imaging of biopsy-proven high-risk primary prostate cancer patients
    Lu, Michelle
    Adler, Stephen
    Lindenberg, Maria Liza
    Mena, Esther
    Turkbey, Ismail
    Seidel, Jurgen
    Choyke, Peter
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [47] Age-Related Use and Perceptions of eHealth in Men With Prostate Cancer: A Web-Based Survey
    Rising, Camella J.
    Bol, Nadine
    Kreps, Gary L.
    JMIR CANCER, 2015, 1 (01):
  • [48] The use of early PSA velocity to predict eventual development of abnormal PSA values: Potential use in the early identification of men at risk for prostate cancer
    Amling, CL
    Riffenburgh, RH
    JOURNAL OF UROLOGY, 2002, 167 (04): : 325 - 325
  • [49] Utility of Biology-Guided Radiotherapy to De Novo Metastases Diagnosed During Staging of High-Risk Biopsy-Proven Prostate Cancer
    Gaudreault, Mathieu
    Chang, David
    Hardcastle, Nicholas
    Jackson, Price
    Kron, Tomas
    Hanna, Gerard G.
    Hofman, Michael S.
    Siva, Shankar
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [50] Distributions and characteristics of initial PSA and PSA velocity in Chinese men aged 50 years and younger without prostate cancer: a multi-center study
    Yang, Wenjun
    Liu, Sirong
    Hu, Cheng
    Xie, Keji
    Wei, Xinghua
    Zeng, Weiwei
    Tang, Ping
    JOURNAL OF BUON, 2019, 24 (02): : 832 - 837
12345